Yi HA, Moller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H (2016) Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease. J Neurol Neurosurg Psychiatry 87, 425-432.
Ledig C, Schuh A, Guerrero R, Heckemann RA, RueckertD (2018) Structural brain imaging in Alzheimer's disease and mild cognitive impairment: Biomarker analysis and shared morphometry database. Sci Rep 8, 11258.
Frisoni GB, Fox NC, Jack CR, Jr., Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC (2008) Volumetric MRI and cognitive measures in Alzheimer disease : Comparison of markers of progression. J Neurol 255, 567-574.
Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, Galluzzi S, Marizzoni M, Frisoni GB (2016) Brain atrophy in Alzheimer's disease and aging. Ageing Res Rev 30, 25-48.
Ferreira D, Verhagen C, Hernandez-Cabrera JA, Cavallin L, Guo CJ, Ekman U, Muehlboeck JS, Simmons A, Barroso J, Wahlund LO, Westman E (2017) Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: Longitudinal trajectories and clinical applications. Sci Rep 7, 46263.
McRae-McKee K, Evans S, Hadjichrysanthou C, Wong MM, de Wolf F, Anderson RM (2019) Combining hippocampal volume metrics to better understand Alzheimer's disease progression in at-risk individuals. Sci Rep 9, 7499.
Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A, Bjerke M, Stroobants S, Engelborghs S, Staelens S (2019) Association of short-Term cognitive decline and MCI-To-AD dementia conversion with CSF, MRI, amyloid-And (18)F-FDG-PET imaging. Neuroimage Clin 22, 101771.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, PhelpsCH(2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
Jack CR, Jr., Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, PhelpsCH(2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Associationworkgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 257-262.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
Sanchez-Benavides G, Gomez-Anson B, Sainz A, Vives Y, Delfino M, Pena-Casanova J (2010) Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer disease subjects. Psychiatry Res 181, 219-225.
Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, deToledo-Morrell L, Killiany RJ, Lehericy S, Pantel J, Pruessner JC, Soininen H, Watson C, Duchesne S, Jack CR, Jr., Frisoni GB (2011) Survey of protocols for the manual segmentation of the hippocampus: Preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis 26 Suppl 3, 61-75.
Niemantsverdriet E, Ribbens A, Bastin C, Benoit F, Bergmans B, Bier JC, Bladt R, Claes L, De Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Lemper JC, Mormont E, Picard G, Salmon E, Segers K, Sieben A, Smeets D, Struyfs H, Thiery E, Tournoy J, Triau E, Vanbinst AM, Versijpt J, Bjerke M, Engelborghs S (2018) A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER). J Alzheimers Dis 63, 1509-1522.
Hurtz S, Chow N, Watson AE, Somme JH, Goukasian N, Hwang KS, Morra J, Elashoff D, Gao S, Petersen RC, Aisen PS, Thompson PM, Apostolova LG (2019) Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability. Neuroimage Clin 21, 101574.
Struyfs H, Sima DM, Wittens M, Ribbens A, Pedrosa de Barros N, Phan TV, Ferraz Meyer MI, Claes L, Niemantsverdriet E, Engelborghs S, Van Hecke W, Smeets D (2020) Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm. Neuroimage Clin 26, 102243.
Martensson G, Hakansson C, Pereira JB, Palmqvist S, Hansson O, van Westen D, Westman E (2020) Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up. Neuroimage Clin 27, 102310.
Schmitter D, Roche A, Marechal B, Ribes D, Abdulkadir A, Bach-Cuadra M, Daducci A, Granziera C, Kloppel S, Maeder P, Meuli R, Krueger G, Alzheimer's Disease Neuroimaging Initiative (2015) An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease. Neuroimage Clin 7, 7-17.
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M, Subjective Cognitive Decline Initiative Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 10, 844-852.
Smeets D, Ribbens A, Sima DM, Cambron M, Horakova D, Jain S, Maertens A, Van Vlierberghe E, Terzopoulos V, Van Binst AM, Vaneckova M, Krasensky J, Uher T, Seidl Z, De Keyser J, Nagels G, De Mey J, Havrdova E, Van Hecke W (2016) Reliable measurements of brain atrophy in individual patients with multiple sclerosis. Brain Behav 6, e00518.
Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van HeckeW, DeMey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D (2015) Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin 8, 367-375.
Boccardi M, Bocchetta M, Apostolova LG, Barnes J, Bartzokis G, Corbetta G, DeCarli C, deToledo-Morrell L, Firbank M, Ganzola R, Gerritsen L, HennemanW, Killiany RJ, Malykhin N, Pasqualetti P, Pruessner JC, Redolfi A, Robitaille N, Soininen H, Tolomeo D, Wang L, Watson C, Wolf H, Duvernoy H, Duchesne S, Jack CR, Jr., Frisoni GB (2015) Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance. Alzheimers Dement 11, 126-138.
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355.
Fischl B (2012) FreeSurfer. Neuroimage 62, 774-781.
R Core Team (2020) R Foundation for Statistical Computing, Vienna, Austria.
Patil I (2018) ggstatsplot: 'ggplot2' Based Plots with Statistical Details. CRAN. https://cran.r-project.org/web/packages/ggstatsplot/index.html
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011) pROC: An open-source package for R and S+to analyze and compare ROC curves. BMC Bioinformatics 12, 77.
DeLong ER, DeLong DM, Clarke-PearsonDL(1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44, 837-845.
Kassambara A (2020) ggpubr: 'ggplot2' Based Publication Ready Plots. Version: R package version 0.4.0. https://CRAN.R-project.org/package=ggpubr.
Kim JH (2019) Multicollinearity and misleading statistical results. Korean J Anesthesiol 72, 558-569.
Backhausen LL, Herting MM, Buse J, Roessner V, Smolka MN, Vetter NC (2016) Quality control of structural MRI images applied using FreeSurfer-A hands-on workflow to rate motion artifacts. Front Neurosci 10, 558.
Aisen PS, Cummings J, Jack CR, Jr., Morris JC, Sperling R, Frolich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B (2017) On the path to 2025: Understanding the Alzheimer's disease continuum. Alzheimers Res Ther 9, 60.
Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE, Alzheimer's Disease Neuroimaging Initiative (2011) Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Gen Psychiatry 68, 961-969.
Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009) Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures. Neurology 72, 999-1007.
Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R, Alzheimer's Disease Neuroimaging Initiative (2008) Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131, 2443-2454.
Hill NL, Mogle J, Wion R, Munoz E, DePasquale N, Yevchak AM, Parisi JM (2016) Subjective cognitive impairment and affective symptoms: A systematic review. Gerontologist 56, e109-e127.
Liew TM (2020) Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alzheimers Res Ther 12, 107.
Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, LaskeC, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, WagnerM(2019) Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study. Alzheimers Res Ther 11, 66.
Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21, 2618-2625.
Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013) Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiol Aging 34, 73-82.
Jacobs HI, Van Boxtel MP, Jolles J, Verhey FR, Uylings HB (2012) Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings. Neurosci Biobehav Rev 36, 297-309.
Franko E, Joly O, Alzheimer's Disease Neuroimaging Initiative (2013) Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy. PLoS One 8, e71354.
Garcia-Ptacek S, Eriksdotter M, Jelic V, Porta-Etessam J, Kareholt I, Manzano Palomo S (2016) Subjective cognitive impairment: Towards early identification of Alzheimer disease. Neurologia 31, 562-571.
Barnes J, Scahill RI, Schott JM, Frost C, Rossor MN, Fox NC (2005) Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord 19, 338-344.
Shi F, Liu B, Zhou Y, Yu C, Jiang T (2009) Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-Analyses of MRI studies. Hippocampus 19, 1055-1064.
Sarica A, Vasta R, Novellino F, Vaccaro MG, Cerasa A, Quattrone A, Alzheimer's Disease Neuroimaging Initiative (2018) MRI asymmetry index of hippocampal subfields increases through the continuum from the mild cognitive impairment to the Alzheimer's disease. Front Neurosci 12, 576.
CareyD, Nolan H, Kenny RA, Meaney J (2019) Dissociable age and memory relationships with hippocampal subfield volumes in vivo: Data from the Irish Longitudinal Study on Ageing (TILDA). Sci Rep 9, 10981.
Zandifar A, Fonov V, Coupe P, Pruessner J, Collins DL, Alzheimer's Disease Neuroimaging Initiative (2017) A comparison of accurate automatic hippocampal segmentation methods. Neuroimage 155, 383-393.
Hett K, Ta VT, Catheline G, Tourdias T, Manjon JV, Coupe P, Alzheimer's Disease Neuroimaging Initiative (2019) Multimodal hippocampal subfield grading for Alzheimer's disease classification. Sci Rep 9, 13845.
